Skip to main content
Created date
Updated date

Quick intro

A mobile application or web-based application is used by a subject of care or carer to manage prescriptions and to present an electronic prescription token to a pharmacy.

A mobile application uses a mobile intermediary system to connect to, and interact with, the National Prescription Delivery Services (NPDS) and/or Active Script List Registry (ASLR).

If you are developing a mobile application as well as the mobile intermediary system it will connect to, please refer to the Electronic prescribing conformance process – mobile intermediary system.

If you are developing a mobile application only, and intend to use a mobile intermediary system developed by another provider that offers connection services, please follow the process below. The process will assist mobile application software developers to connect to a mobile intermediary system provider and declare software conformance with the Agency’s electronic prescribing technical framework.

1: Connect with a mobile intermediary

Please contact your preferred conformant mobile intermediary system provider to gain access to test environments and the interface technical specifications required to connect to their service. 

You may contact [email protected] for information about conformant mobile intermediary system providers that offer connection services. 

2: Develop your product

Within the Technical Framework Documents, identify the requirements that apply to your product in the Electronic Prescribing – Conformance Profile.

To assist your development and testing, refer to the Electronic Prescribing – Conformance Test Specifications (CTS) and test data. 

Begin developing your product by using the interface technical specifications and test environment provided by your mobile intermediary system provider. 

3: Conduct internal testing

Conduct a self-assessment against the applicable requirements and your own internal testing. 

4: Complete the Conformance Test Specification

Complete the CTS and submit to your preferred conformant mobile intermediary system provider.

Please ensure the CTS for your product is completed in full, with:

  • the relevant test outcomes (pass, fail, N/A) recorded against each test case
  • a corresponding reason documented for any test marked as N/A 
  • completed Test Summary Report worksheet
  • relevant evidence for each test outcome, including screenshots, recordings, documentation or other.

5: Conduct conformance assessment

Your mobile intermediary system provider will conduct your conformance assessment observation session. 

The purpose of this session is to verify the results recorded in your submitted CTS and validate any further information requested by your mobile intermediary system provider. 

Your mobile intermediary system provider will help you determine if you are ready to undergo observation and will schedule the session at a mutually agreed time.

In addition to your observed conformance assessment, your mobile intermediary system provider may request further evidence for specific test cases to ensure the record of the test is full and accurate.

6: Declare conformance

Complete the Electronic Prescribing – Conformance Vendor Declaration form after the observed conformance assessment is successfully completed. Email your form to [email protected]. Please ensure that: 

  • you have completed all relevant information, such as inclusion of companion software details in section 1.3. Companion software may include Prescription Delivery Services adaptor(s), workflow engine(s), mobile gateway(s), etc.
  • you include the name of the Mobile Intermediary System your software product is integrated with. 
  • the information in the form matches the information in the Test Summary Report tab in the final CTS.

7: Deploy updated product

Once you have received a notification that your product has been included on the list of conformant products, you may commence deploying electronic prescribing functionality into production.


You should now be able to gain conformance with the Agency’s electronic prescribing technical framework for your mobile application. If you need any further assistance, please contact [email protected].